BAM-15
Preclinical ResearchBAM15
A mitochondrial uncoupler researched for fat loss and metabolic improvement without the cardiovascular toxicity of older uncoupling agents.
Dose
5-10 mg
Route
Oral
Cycle
Research protocols commonly discuss durations of 4-8 weeks.
Storage
Not applicable; BAM15 is typically stored as a powder.
What is BAM-15?
BAM15 (N5,N6-Bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine) is a novel mitochondrial protonophore, or uncoupler, that has been extensively studied for its potential in metabolic research. Unlike older uncoupling agents like DNP, BAM15 has shown promise in animal studies for increasing metabolic rate and reducing adiposity without hyperthermia or cardiovascular toxicity. It functions by disrupting the mitochondrial proton gradient, leading to increased oxygen consumption and energy expenditure, primarily as heat, rather than ATP synthesis. This mechanism is being explored for applications in weight management, insulin sensitivity improvement, and general metabolic health.
Key Benefits
- Fat loss through mitochondrial uncoupling
- No cardiovascular toxicity in animal studies
- Metabolic rate increase
- Insulin sensitivity improvement
Mechanism of Action
- Proton uncoupler in mitochondria
- Increases metabolic rate by reducing ATP production efficiency
- Dissipates energy as heat
Best For
- Fat loss research
- Metabolic research
- Mitochondrial research
Body Systems
🐾 Griffin Says...
Molecular Information
Molecular weight
339.73 g/mol
Type
Small molecule uncoupler
Pharmacokinetics
Time to peak
Approximately 1-2 hours (in animal models, human data limited)
Half-life
1.5 h
Time to clear
Within 24 hours based on short half-life
Research on BAM15 indicates a short half-life, with rapid metabolism and excretion.
Research Indications
Fat Loss
Research indicates BAM15 promotes fat loss in animal models by increasing energy expenditure through mitochondrial uncoupling, without significant effects on food intake.
Metabolic Rate Increase
Studies show BAM15 increases basal metabolic rate by dissipating the proton gradient across the inner mitochondrial membrane, leading to uncoupled respiration.
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Induce fat loss and increase metabolic rate | 5-10 mg/kg (in animal models, human equivalent dose research is ongoing) | Once daily | Oral |
| Improve insulin sensitivity in diet-induced obesity models | 2.5-5 mg/kg (in animal models) | Once daily | Oral |
| Study acute thermogenic effects | Higher single doses, e.g., 10-20 mg/kg (in acute animal studies) | Single administration | Oral |
| Investigate long-term metabolic adaptations | 5 mg/kg (in animal models) | Once daily for extended periods (e.g., 8-12 weeks) | Oral |
| Evaluate interaction with other metabolic compounds | Variable, adjusted based on concurrent compound (in animal models) | Daily | Oral |
Oral administration is the standard route for BAM15 in research.
Peptide Interactions
- Monitor Combination
Compounds affecting mitochondrial function (e.g., certain AMPK activators)
Potential for synergistic or additive effects on energy metabolism; careful monitoring in research settings is warranted.
- Use Caution
Glucose-lowering medications
BAM15 may improve insulin sensitivity, potentially necessitating dose adjustments of glucose-lowering agents in research models to prevent hypoglycemia.
- Monitor Combination
Thyroid hormones
Both thyroid hormones and uncouplers can influence basal metabolic rate. Close observation in research is recommended to avoid excessive metabolic stimulation.
- Avoid
Other thermogenic agents
Combining BAM15 with other compounds that significantly increase heat production may lead to dangerously high body temperatures (hyperthermia) in research subjects.
- Synergistic
High-fat diet (in research models)
Research often uses high-fat diet models to demonstrate BAM15's efficacy in combating diet-induced obesity and metabolic dysfunction.
How to Reconstitute
- 1Obtain BAM15 in powder form.
- 2Carefully weigh the desired amount of BAM15 using a precision scale.
- 3Dissolve the measured BAM15 into a suitable solvent, such as DMSO or ethanol, to create a stock solution for further dilution.
- 4For oral administration in research, dilute the stock solution further in water or another inert liquid carrier.
- 5Ensure complete dissolution and homogeneity of the solution before administration.
BAM15 is typically dissolved in an appropriate solvent for oral research administration.
What to Expect
- Weeks 1-2: Initial metabolic changes, potentially including increased energy expenditure and mild thermogenesis, may be observed in research subjects.
- Weeks 2-4: Consistent administration in research protocols may lead to noticeable reductions in body fat and improvements in markers of metabolic health.
- Weeks 4-6: Continued research suggests sustained effects on weight management and potentially enhanced insulin sensitivity.
- Beyond 6 weeks: Long-term effects and safety are still under active investigation; research protocols often include monitoring for metabolic adaptation.
Side Effects & Safety
| Effect | Frequency | Severity |
|---|---|---|
| Limited human data | Unknown | Unknown |
| Potential hyperthermia at high doses | Theoretical | Serious |
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open CalculatorPeptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.